FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2603064341> ?p ?o ?g. }

• W2603064341 abstract "Over the last decades, biotechnology has become a very promising industry and is seen as a key area for thriving innovation in the future. In order to realize this potential for their economies, many countries including the Netherlands have made special policies containing governmental subsidies and credits aimed to increase the number of biotechnology startups and help them in becoming a success. This report has as goal to measure the impact of one of these credits, namely governmental subsidized hire-purchase facilities for biotechnology startups. If such a startup is in need of specialized equipment or facility they can apply for a hire-purchase investment. The foundation which governs the funds, called Mibiton checks this application and if it is granted the machinery is bought by them and hired to the applicant, who has to pay a representative monthly fee for its use. Beforehand a period is determined in which the company pays for the total value of the machine and when the period is finished the ownership is converted to them. With regard to the measurement of the impact of such a fund an interesting discussion applies. It is argued in the literature that governmental sponsorship can be positive or negative for a starting company, depending whether the investments are helping to strengthen the company’s initial strategic and competitive advantages or are creating an extra advantage with the extra resources. In the last case there is the risk that a company can become too dependent on the sponsorship in order to compete with its competitor, which leads to big problems when the sponsorship finished and ultimately the company can go bankrupt if it is not able to turn around to a more sustainable situation. There is however no tool available that can easily show both the financial and strategically impact of a hire-purchase investment for the companies, the fund and the sector as a whole. So in this report a special measurement protocol is developed based on three sub instruments. First of all a multiplier is used which expresses the social-economical revenues directly for the company, indirectly for its customers and suppliers and as induced effects for the society as a whole. Not only the financial data is included in the revenues, but also estimates are included of the revenues by employee growth, knowledge increase, etc. The problem with the multiplier is that it neglects the induced investments effects, which are the extra revenues caused by a shorter development time or time-to-market. In order to capture these effects the second sub instrument is the accelerator which expresses the decrease on a time-scale. However both instruments are still not measuring whether the investments are giving strategically or competitive advantages and therefore the impact effect is introduced which divides the investments into four categories ranging from no advantage to major advantages. In the background interviews done for this research another interesting problem was mentioned. It was said to be very hard to get a private hire-purchase investment because the equipment in the biotechnology sector has a fast depreciation period and as there are no second-hand market investors see it as a too risky investment and certainly at startups that are also lacking a track record. However there is very little research done in the literature to either confirm or dismiss this claims. Therefore this report is aiming to fill this gap. In order to measure the impact managers and directors of nineteen companies are interviewed. With the data gathered from these interviews there is tried to find the multiplier revenues, the acceleration and the impact effect for each of the companies. Also there is tried to look into the importance of equipment for these companies and the problems with financing them. Finally there is looked to the trends represented by the figures and conclusions are drawn upon them. After looking into the results it can be concluded that Mibiton investments in general have a strategically effect on the companies and the fund can therefore be put in the category of credits giving a strategically and competitive advantage for companies. This is illustrated by the fact that 17 of the 19 companies have experienced a decrease in development time and 12 of them where in the highest two categories of the impact effect. Also the average direct effect multiplier of 3.11 and the average acceleration of 10.7 months are relatively high and are therefore confirming this picture. There should be noted that it was not possible to get solid figures for the indirect and induced effect multiplier as only very 5 companied could make an estimate of the effects for their suppliers and customers and only 1 company could say something about the effects for the sector and society. Also many of the interviewed companies affirmed that equipment and facilities are very important for the Life Sciences sector and that it was very difficult to finance them. So also the extra claim is confirmed in this report. Finally the main contribution of this report lies in the developed tool to measure the impact, including the multiplier, accelerator and impact effect. For further research it could be very interesting to develop this tool even more and check its range and shortcomings. Also it would be interesting to check the impact of other governmental credits to determine what the best tool is." @default.
• W2603064341 created "2017-04-07" @default.
• W2603064341 creator A5042364926 @default.
• W2603064341 date "2012-01-01" @default.
• W2603064341 modified "2023-09-27" @default.
• W2603064341 title "Measuring the impact of government subsidized hire-purchase facilities by starting biotechnology companies." @default.
• W2603064341 hasPublicationYear "2012" @default.
• W2603064341 type Work @default.
• W2603064341 sameAs 2603064341 @default.
• W2603064341 citedByCount "0" @default.
• W2603064341 crossrefType "journal-article" @default.
• W2603064341 hasAuthorship W2603064341A5042364926 @default.
• W2603064341 hasConcept C10138342 @default.
• W2603064341 hasConcept C138885662 @default.
• W2603064341 hasConcept C144024400 @default.
• W2603064341 hasConcept C144133560 @default.
• W2603064341 hasConcept C162324750 @default.
• W2603064341 hasConcept C162853370 @default.
• W2603064341 hasConcept C17744445 @default.
• W2603064341 hasConcept C182306322 @default.
• W2603064341 hasConcept C199539241 @default.
• W2603064341 hasConcept C27548731 @default.
• W2603064341 hasConcept C2776745293 @default.
• W2603064341 hasConcept C2778137410 @default.
• W2603064341 hasConcept C34447519 @default.
• W2603064341 hasConcept C36289849 @default.
• W2603064341 hasConcept C41895202 @default.
• W2603064341 hasConcept C84265765 @default.
• W2603064341 hasConcept C94625758 @default.
• W2603064341 hasConceptScore W2603064341C10138342 @default.
• W2603064341 hasConceptScore W2603064341C138885662 @default.
• W2603064341 hasConceptScore W2603064341C144024400 @default.
• W2603064341 hasConceptScore W2603064341C144133560 @default.
• W2603064341 hasConceptScore W2603064341C162324750 @default.
• W2603064341 hasConceptScore W2603064341C162853370 @default.
• W2603064341 hasConceptScore W2603064341C17744445 @default.
• W2603064341 hasConceptScore W2603064341C182306322 @default.
• W2603064341 hasConceptScore W2603064341C199539241 @default.
• W2603064341 hasConceptScore W2603064341C27548731 @default.
• W2603064341 hasConceptScore W2603064341C2776745293 @default.
• W2603064341 hasConceptScore W2603064341C2778137410 @default.
• W2603064341 hasConceptScore W2603064341C34447519 @default.
• W2603064341 hasConceptScore W2603064341C36289849 @default.
• W2603064341 hasConceptScore W2603064341C41895202 @default.
• W2603064341 hasConceptScore W2603064341C84265765 @default.
• W2603064341 hasConceptScore W2603064341C94625758 @default.
• W2603064341 hasLocation W26030643411 @default.
• W2603064341 hasOpenAccess W2603064341 @default.
• W2603064341 hasPrimaryLocation W26030643411 @default.
• W2603064341 hasRelatedWork W160945218 @default.
• W2603064341 hasRelatedWork W1975794289 @default.
• W2603064341 hasRelatedWork W2225115163 @default.
• W2603064341 hasRelatedWork W2276033416 @default.
• W2603064341 hasRelatedWork W2325274998 @default.
• W2603064341 hasRelatedWork W2407700273 @default.
• W2603064341 hasRelatedWork W245702615 @default.
• W2603064341 hasRelatedWork W2472416067 @default.
• W2603064341 hasRelatedWork W2497482695 @default.
• W2603064341 hasRelatedWork W268944157 @default.
• W2603064341 hasRelatedWork W2745695739 @default.
• W2603064341 hasRelatedWork W2939274588 @default.
• W2603064341 hasRelatedWork W2955312244 @default.
• W2603064341 hasRelatedWork W3124888154 @default.
• W2603064341 hasRelatedWork W314180267 @default.
• W2603064341 hasRelatedWork W371210617 @default.
• W2603064341 hasRelatedWork W73642835 @default.
• W2603064341 hasRelatedWork W15220208 @default.
• W2603064341 hasRelatedWork W2163519185 @default.
• W2603064341 hasRelatedWork W2600566427 @default.
• W2603064341 isParatext "false" @default.
• W2603064341 isRetracted "false" @default.
• W2603064341 magId "2603064341" @default.
• W2603064341 workType "article" @default.